FSRH CEU Statement: Management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants (March 2017)
File size 292KB | Date: 01 March 2017
New guidance on management of anticoagulants or antiplatelet medications
Posted 29 March 2017
Date: 29 Mar 2017
Type: FSRH News and Information
CEU publishes new guidance on the management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants.
This new guidance aims to encourage the consistent and safe management of women requesting intrauterine contraception (IUC) and subdermal implants (SDI) who are taking anticoagulants or antiplatelet medications.
It is primarily aimed at clinicians working in primary care and community sexual and reproductive health clinics.
Read the full document below.
Related Documents